Ridaura Oral Capsule 3Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ridaura: Oral capsule (3mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2912.JPG
Ridaura 3mg Cap
Connetics Corporation a division of Stiefel Laboratories a GSK Company
Pill Identification: RIDAURA RIDAURA 
Drug Image file DrugItem_4471.JPG
Ridaura 3mg Cap
Prometheus Laboratories Inc
Pill Identification: RIDAURA RIDAURA 

What is this Medicine?

AURANOFIN (au RANE oh fin) is a gold compound. It is used to treat rheumatoid arthritis when other medicines have not worked.

In-Depth Information
Select a Medication

Ridaura 3mg Capsule

NDC: 654830093
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Rheumatoid Arthritis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Ridaura 3mg Capsule
Drug Image file DrugItem_4471.JPG
Prometheus Laboratories Inc
Pill Identification: RIDAURA RIDAURA 
Shape: capsule
Color: beige,brown

Reported Side Effects for Ridaura 3mg Capsule

Lung Inflammation Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Difficulty Swallowing Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Type Of Anemia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Aplastic Anemia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Intestine Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Pancytopenia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Intestinal Bleeding Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Gum Inflammation Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Melena Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Inflamed Tongue Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Hair Loss Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
1.0-3.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
3.0-9.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Protein In The Urine Incidence:
3.0-9.0%*
Severity: SEVERE
Onset: DELAYED
Conjunctivitis Incidence:
3.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
13.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
17.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
24.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
47.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ridaura

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5